Dewpoint Therapeutics



Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.

Ameet Nathwani
Isaac Klein
Chief Scientific Officer
Lori Escobedo
Chief People Officer
Peter Dandliker
VP, Condensate Platform
Geoff Stamper
VP, New Product Strategy
Scott Peterson
VP, Business Development
Rebecca Zacks
VP, Community & Content
Alexander Szewczak
VP, Discovery Operations & Data Analytics
Will Chen
VP, Computational Biology & Human Genetics
Sharon Klahre
VP, Investor Relations & Strategic Finance
Marc W. Hentz
MD, Dewpoint Dresden
Lili Zhang
Senior Director, Discovery Biology
Suguna Rachakonda
Senior Director, Strategy & Business Development
Marie Hanabusa
Senior Manager, PMO Collaboration Lead
Bobby Ingram
Manager, Information Technology
Chi Zhang
Group Leader
Nick Ramirez
Lab Operations Assistant
Kelly Clark
Head of Project & Portfolio Management
Sarah Birke
Lab Operations Assistant
Alex Milot
Senior Research Associate
Miook Cho
Senior Scientist
Christiane Iserman
Senior Scientist
Edgar Boczek
Senior Scientist
Jesse Lai
Senior Scientist
Anneke Kramm
Associate Director, Project Management
Arlette Gutierrez
Administrative Coordinator, People & Culture

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.